| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $13.4M | — | -5.2% |
| Cost of Revenue | $7.0M | — | +0.2% |
| R&D Expense | $1.4M | — | -9.7% |
| SG&A Expense | $2.5M | — | -77.3% |
| Operating Income | $2.2M | — | +138.7% |
| Income Tax | $0 | — | — |
| Net Income | $36.3M | — | +232.9% |
| EPS (Basic) | $1.56 | — | +167.2% |
| EPS (Diluted) | $0.00 | — | +100.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $12.5M | -3.7% | -36.1% |
| Short-term Investments | $1.0M | -80.0% | -82.4% |
| Accounts Receivable | $4.9M | -23.2% | -28.9% |
| Inventory | $23.1M | +7.3% | +50.7% |
| Current Assets | $42.4M | -9.3% | -13.8% |
| Total Assets | $66.2M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$4.3M | — | +38.4% |
| Capital Expenditures | $6K | — | +0.0% |
| Investing Cash Flow | $4.0M | — | +653.3% |
| Financing Cash Flow | -$209K | — | -102.2% |
| Free Cash Flow | -$4.3M | — | +38.4% |
| -9.2% |
| Current Liabilities | $17.8M | -56.1% | -34.5% |
| Total Liabilities | $41.6M | -50.2% | -48.8% |
| Stockholders' Equity | $10.8M | +141.5% | +148.7% |